To investigate how the inhibition of GSK-3β phosphorylation by O-GlcNAcylation affects cardiac hypertrophy and function in vivo, we injected TDZD-8, in Ogt-Tg mice before TAC. The gene discussed is OGT; the disease is cardiac hypertrophy.